创新!14家正在颠覆世界的医疗健康创业公司

2016-02-09 MedSci MedSci原创

医疗领域 1、Editas Editas是一家采用 CRISPR 进行进行基因编辑的公司。该公司已经和多家公司合作,在镰刀形红细胞贫血症、LCA10、血癌治疗方面有着巨大进展。这家公司是由华人科学家张锋发起成立。 已披露的总融资金额:1.63亿美元 部分投资者:Flagship Ventures、 Polaris Partners、 Third Rock Ventures、 T.

医疗领域

1、Editas

创新!14家正在颠覆世界的医疗健康创业公司

Editas是一家采用 CRISPR 进行进行基因编辑的公司。该公司已经和多家公司合作,在镰刀形红细胞贫血症、LCA10、血癌治疗方面有着巨大进展。这家公司是由华人科学家张锋发起成立。

已披露的总融资金额:1.63亿美元

部分投资者:Flagship Ventures、 Polaris Partners、 Third Rock Ventures、 T. Rowe Price、 Viking Global Investors、 Google Ventures、 Fidelity Investments、 Partners Innovation Fund、 Casdin Capital

同类公司:CRISPR Therapeutics

2、EpiBone

创新!14家正在颠覆世界的医疗健康创业公司

EpiBone 利用干细胞和一种特殊类型的培养皿,生长出了耐用的活体骨头。

已披露的总融资金额:35万美元

部分投资者:Breakout Labs

3、Human Longevity

创新!14家正在颠覆世界的医疗健康创业公司

Human Longevity 公司利用基因组和干细胞疗法,寻找相应的治疗药物,从而让老年人延缓衰老,保持健康和身体机能。

已披露的总融资金额:7000万美元

部分投资者:raper Fisher Jurvetson

同类公司: Color Genomics

4、Intarcia Therapeutics

创新!14家正在颠覆世界的医疗健康创业公司

Intarcia Therapeutics 致力于研发结合科技与药物的创新性疗法,并主要专注于流行病和极难控制的疾病。自2012年以来,该公司一直从事于一年使用一次的糖尿病疗法的开发。

已披露的总融资金额:6亿8千90万美元

部分投资者:Brentwood Associates、 Delphi Ventures、 Alta Partners、 New Enterprise Associates、 Venrock

5、One Medical Group

创新!14家正在颠覆世界的医疗健康创业公司

One Medical Group 是一家美国医疗健康公司,通过数字化技术提高医疗系统效率,比如远程医疗。

已披露的总融资金额:1亿1750万美元

部分投资者:Benchmark Capital、 DAG Ventures、 Serent Capital、 Oak Investment Partners、 Maverick Capital

6、Stemcentrx

创新!14家正在颠覆世界的医疗健康创业公司

Stemcentrx 是一家通过干细胞研究医疗癌症的公司。

已披露的总融资金额:3.7亿美元

部分投资者:ARTIS Ventures、 Elon Musk、 Fidelity Investments、 Founders Fund、 Sequoia Capital

7、SynCardia Systems

创新!14家正在颠覆世界的医疗健康创业公司

SynCardia Systems 生产人工心脏,用于心脏病人需要心脏移植的手术中。

已披露的总融资金额:550万美元

部分投资者:Desert Angels、 Solstice Capital、 Athyrium Capital Management、 SWK Holdings

数字健康

8、Cue

创新!14家正在颠覆世界的医疗健康创业公司

Cue 是一家生产面向消费者的深度健康追踪设备的公司,通过五个核心指标来判定用户的健康水平,该设备也可以和手机配合使用。

已披露的总融资金额:750万美元

部分投资者:Immortalana、 Sherpa Capital

9、Proteus Digital Health

创新!14家正在颠覆世界的医疗健康创业公司

Proteus Digital Health 通过对其传感器收集的健康数据进行分析,为用户提供一份详细的健康状况分析。

已披露的总融资金额:3亿6720万美元

部分投资者:Adams Street Partners、 Spring Ridge Ventures、 The Carlyle Group、 Asset Man- agement Ventures、 Fletcher Spaght Ventures、 Kaiser Permanente Ventures、 Novartis、 Oracle、 Frazier Healthcare Partners

10、hync

创新!14家正在颠覆世界的医疗健康创业公司

hync 是一家可穿戴设备厂商,通过神经信号算法来改善用户的精神状况。

已披露的总融资金额:1300万美元

部分投资者: Andreessen Horowitz、 Khosla Ventures

11、Flatiron Health

创新!14家正在颠覆世界的医疗健康创业公司

Flatiron Health 是一家癌症大数据公司,建立了专门针对肿瘤的云数据存储和分析平台 OncologyCloud,通过分析癌症的相关数据帮助病人获得临床治疗的建议。

已披露的总融资金额:1380万美元

部分投资者:BoxGroup、 First Round Capital、 Google Ventures、 SV Angel、 The Social+Capital Partnership

12、Oscar Health Insurance

创新!14家正在颠覆世界的医疗健康创业公司

Oscar Health Insurance 是一家结合高科技与保险业务的纽约初创公司,致力于让保险变得简单透明。

已披露的总融资金额:3.27亿美元

部分投资者:BoxGroup、 Founders Fund、 General Catalyst Partners、 Khosla Ventures、 Red Swan Ventures、 SV Angel、 Thrive Capital

13、Glooko

创新!14家正在颠覆世界的医疗健康创业公司

Glooko 通过 iPhone 应用记录患者的血糖情况,支持17种不同的血糖仪,方便患者和医生随时观测血糖变化。

已披露的总融资金额:2800万美元

部分投资者:Canaan Partners、 LifeForce Ventures、 Medtronic、 Samsung Ventures、 The Social+Capital Partnership

14、Psious

创新!14家正在颠覆世界的医疗健康创业公司

Psious 通过虚拟现实、增强现实工具来治疗病人的精神疾病。

已披露的总融资金额:1100 万美元

部分投资者:Rothenberg Ventures、 River Accelerator

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=64156, encodeId=35a6641563e, content=嗯,思考, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64157, encodeId=efae6415ec2, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285243, encodeId=55fb128524300, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513781, encodeId=8bb41513e8130, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63814, encodeId=af406381462, content=很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d9077449, createdName=lpapple, createdTime=Tue Feb 09 16:35:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63808, encodeId=bbc1638081f, content=好。值得思考!, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Tue Feb 09 14:25:00 CST 2016, time=2016-02-09, status=1, ipAttribution=)]
    2016-02-13 lietome1

    嗯,思考

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=64156, encodeId=35a6641563e, content=嗯,思考, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64157, encodeId=efae6415ec2, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285243, encodeId=55fb128524300, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513781, encodeId=8bb41513e8130, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63814, encodeId=af406381462, content=很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d9077449, createdName=lpapple, createdTime=Tue Feb 09 16:35:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63808, encodeId=bbc1638081f, content=好。值得思考!, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Tue Feb 09 14:25:00 CST 2016, time=2016-02-09, status=1, ipAttribution=)]
    2016-02-13 lietome1

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=64156, encodeId=35a6641563e, content=嗯,思考, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64157, encodeId=efae6415ec2, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285243, encodeId=55fb128524300, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513781, encodeId=8bb41513e8130, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63814, encodeId=af406381462, content=很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d9077449, createdName=lpapple, createdTime=Tue Feb 09 16:35:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63808, encodeId=bbc1638081f, content=好。值得思考!, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Tue Feb 09 14:25:00 CST 2016, time=2016-02-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=64156, encodeId=35a6641563e, content=嗯,思考, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64157, encodeId=efae6415ec2, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285243, encodeId=55fb128524300, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513781, encodeId=8bb41513e8130, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63814, encodeId=af406381462, content=很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d9077449, createdName=lpapple, createdTime=Tue Feb 09 16:35:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63808, encodeId=bbc1638081f, content=好。值得思考!, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Tue Feb 09 14:25:00 CST 2016, time=2016-02-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=64156, encodeId=35a6641563e, content=嗯,思考, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64157, encodeId=efae6415ec2, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285243, encodeId=55fb128524300, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513781, encodeId=8bb41513e8130, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63814, encodeId=af406381462, content=很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d9077449, createdName=lpapple, createdTime=Tue Feb 09 16:35:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63808, encodeId=bbc1638081f, content=好。值得思考!, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Tue Feb 09 14:25:00 CST 2016, time=2016-02-09, status=1, ipAttribution=)]
    2016-02-09 lpapple

    很不错

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=64156, encodeId=35a6641563e, content=嗯,思考, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=64157, encodeId=efae6415ec2, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Sat Feb 13 11:40:00 CST 2016, time=2016-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285243, encodeId=55fb128524300, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513781, encodeId=8bb41513e8130, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Feb 10 22:56:00 CST 2016, time=2016-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63814, encodeId=af406381462, content=很不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d9077449, createdName=lpapple, createdTime=Tue Feb 09 16:35:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63808, encodeId=bbc1638081f, content=好。值得思考!, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Tue Feb 09 14:25:00 CST 2016, time=2016-02-09, status=1, ipAttribution=)]
    2016-02-09 dhzzm

    好。值得思考!

    0

相关资讯

8项医疗职业资格认证取消!

经李克强总理签批,国务院日前印发《关于取消一批职业资格许可和认定事项的决定》。2014年以来,国务院已经先后分四批取消了211项职业资格,本次再取消61项,至此,国务院公布取消的职业资格达到272项。 在本次签批的61项职业资格中,与卫生系统有关的包括8项。尘肺诊断医师资格、职业中毒诊断医师资格、物理因素职业病诊断医师资格、全国职业性放射病诊断医师资格,四项水平评价类职业资格整合为“职业

普华永道:2016年医疗行业影响很大的十股力量

对于医疗消费者们而言,随着不同的医疗组织以及创新工具和服务进入新医疗经济中,近在眼前的2016年将是充满新鲜感的一年。普华永道(PwC)旗下的医疗研究所(HRI)在其新近发布的年度《医疗行业关键问题》报告中,为我们预测了2016年医疗行业影响最大的十股力量。 关键点之一: 并购热潮 2016年,备受瞩目的并购热潮很可能会持续,而焦点仍会聚集在保险公司上,因为其会确保监管机构相信,行业整合将

日本医疗再次被评为全球领先,中国位居第…看完我的内心是奔溃的

世界卫生组织(WHO)在最新的报告《World HealthReport》中,从“医疗水平”,“接受医疗服务的难度”,“医药费负担公平性”等方面对世界各国的医疗体系进行了综合比较。 日本因为“高品质的医疗服务”和“医疗负担的平等程度”,“国民平均寿命高”等原因,再次蝉联第一位。中国位居第64位。 其实,日本从政府层面对国民健康加以管理可以追溯到1978年。当时日

医界呼吁分级诊疗:不是任何病都要找专家

医界呼吁分级诊疗:不是任何病都要找专家 “无论互联网技术多么先进发达,都取代不了医院。未来的医院跟今天的医院相比也不会有什么变化,变化的只是医护人员的服务模式、服务流程。”首都医科大学附属北京朝阳医院执行院长陈勇20日在生命时报社举办的“健康人·中国梦2016论坛”上表示,医院的人文关怀及治疗方案是机器和技术所无法取代的。 在互联网医疗的冲击下,传统医院优势该如何面对?与会专家

Lancet增刊:来自中国民营医院医生发表的中国医疗现状调查研究

在2015年第386卷的The Lancet上你可以搜索到一篇论文摘要,题为:“Doctor and patient perceptions on health care in Shanghai hospitals: a cross-sectional survey”,第一作者是周璐靖,单位是“中国上海瑞慈医疗集团,诊所事业部”。虽然,这篇文章实际上是在柳叶刀-中国医学科学院医学科学峰会上的会

全国互联网医疗区域手术中心--“微医集团(杭州)手术中心”启用

1月17日,患者在微医集团杭州手术中心就诊。当日,全国首个互联网医疗区域手术中心“微医集团(杭州)手术中心”在浙江杭州正式投入使用。微医集团杭州手术中心由微医集团与浙江萧山医院共建,依托萧山医院的技术保障,结合微医集团的专家团队,手术中心将能为杭州及周边城市患者提供术前诊断、手术治疗到术后康复的一站式个体化医疗服务。一整套流程下来,患者可“点名医”来家门口手术,并通过微医集团的“大数据平台”进行后